Slow component-b (SCb) translocates ϳ200 diverse proteins from the cell body to the axon and axon tip at average rates of ϳ2-8 mm/d. Several studies suggest that SCb proteins are cotransported as one or more macromolecular complexes, but the basis for this cotransport is unknown. The identification of actin and myosin in SCb led to the proposal that actin filaments function as a scaffold for the binding of other SCb proteins and that transport of these complexes is powered by myosin: the "microfilament-complex" model. Later, several SCb proteins were also found to bind F-actin, supporting the idea, but despite this, the model has never been directly tested. Here, we test this model by disrupting the cytoskeleton in a live-cell model system wherein we directly visualize transport of SCb cargoes. We focused on three SCb proteins that we previously showed were cotransported in our system: ␣-synuclein, synapsin-I, and glyceraldehyde-3-phosphate dehydrogenase. Disruption of actin filaments with latrunculin had no effect on the velocity or frequency of transport of these three proteins. Furthermore, cotransport of these three SCb proteins continued in actin-depleted axons. We conclude that actin filaments do not function as a scaffold to organize and transport these and possibly other SCb proteins. In contrast, depletion of microtubules led to a dramatic inhibition of vectorial transport of SCb cargoes. These findings do not support the microfilament-complex model, but instead indicate that the transport of protein complexes in SCb is powered by microtubule motors.
Introduction
Axonal transport conveys proteins from the neuronal perikarya into axons and axon terminals in two overall rate classes, fast and slow axonal transport. The fast component (FC) delivers mainly membrane-bound organelles at average rates of 50 -400 mm/d. Slow axonal transport consists of two fairly distinct subcomponents termed slow components a and b (SCa and SCb, respectively) . SCa transports microtubules and neurofilaments at average rates of Ϸ1 mm/d. SCb moves at average rates of 2-8 mm/d and transports Ϸ200 proteins, of which only a handful have been identified. Among these are myosin, dynein, clathrin, calmodulin, synapsin, ␣-synuclein, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), superoxide dismutase-1, phosphofructokinase, ubiquitin, molecular chaperones, tau and other microtubule-associated proteins (MAPs), spectrin, actindepolymerizing factor, and actin (Willard et al., 1974; Black and Lasek, 1979; Brady et al., 1981; Garner and Lasek, 1982; Lasek et al., 1984; Baitinger and Willard, 1987; Nixon et al., 1990; Bray et al., 1992; Mercken et al., 1995; Dillman et al., 1996; Yuan et al., 1999; Ma et al., 2000; Bourke et al., 2002; Li et al., 2004) . Clearly, the proteins of SCb are functionally diverse, play critical roles in maintaining the integrity of axons and synapses, and are implicated in neurodegenerative diseases . Early radiolabeling studies suggested that many SCb proteins move together in the axons as if they are components of a common cargo (Willard et al., 1974; Black and Lasek, 1980; Tytell et al., 1981; Garner and Lasek, 1982; Yuan et al., 1999) . More recently, using time-lapse imaging, we have shown that the SCb proteins ␣-synuclein, synapsin-I, and GAPDH are cotransported in axons as components of a discrete complex (Roy et al., 2007) . In the present study, we explore some of the mechanisms underlying SCb transport.
The identification of actin in SCb (Willard et al., 1974; Black and Lasek, 1979) led to the proposal that actin filaments function in SCb transport in two different contexts. First, F-actin and its motor myosin could power the transport of SCb. The identification of myosin in SCb (Willard, 1977) provided additional support for this notion. Second, F-actin could function as a carrier/ scaffold for the transport of other SCb proteins. The observations that proteins of SCb (but not SCa or FC) are concentrated in the actin-rich subaxolemmal region of the axon (Levine and Willard, 1981; Heriot et al., 1985) and that several SCb proteins, including synapsin, spectrin, GAPDH, clathrin, and heat shock proteins, can bind to actin filaments (Bahler and Greengard, 1987; Minaschek et al., 1992; Moss et al., 1992) further support the idea. Based on early observations, the "microfilament-complex" model was proposed, in which actin filaments serve as a scaffold to which SCb proteins bind directly or indirectly, and the complex of F-actin and associated SCb proteins is transported within the axon, powered by myosin . Indeed, actin does perform scaffolding functions in a variety of cellular contexts, including presynaptic boutons (Sankaranarayanan et al., 2003) , lending credence to the idea. However, the microfilament-complex model is based entirely on circumstantial evidence, and other indirect data have been used to argue against this model (Bray et al., 1992; Yuan et al., 1999) . With the development of live-cell model systems, we can now directly test the role of F-actin in SCb transport. In this study, we determined the effects of F-actin disruption on the transport of SCb cargoes and thereby directly tested essential tenets of the microfilamentcomplex model.
Materials and Methods
Immunofluorescence and cDNA constructs. For immunofluorescence studies of mouse and human ␣-synuclein, an affinity-purified rabbit polyclonal (SNL-1) was used (Giasson et al., 2000) . To detect microtubules and actin filaments, we used an antibody to tubulin (DM1-␣; Sigma, St. Louis, MO) and Alexa-488 and 594-labeled phalloidin (Invitrogen, Carlsbad, CA). For detecting ␣-synuclein, neurons were fixed with 4% paraformaldehyde and 120 mM sucrose for 10 min, extracted with 0.25% Triton X-100, blocked with 1% bovine serum albumin and 5% fetal bovine serum, and then incubated with the primary and secondary antibodies. To visualize actin and microtubules optimally, we simultaneously fixed/extracted neurons with paraformaldehyde/glutaraldehyde in a cytoskeletonstabilizing buffer as described previously (Slaughter et al., 1997) . The cDNA constructs, monomeric red fluorescent protein tagged to ␣-synuclein (mRFP::␣-SYN), green fluorescent tagged to ␣-synuclein (GFP::␣-SYN), GFP tagged to synapsin-I (GFP::SYS-I), GFP tagged to GAPDH (GFP::GAPDH), and amyloid precursor protein tagged to yellow fluorescent protein (APP::YFP), have been described previously (Kaether et al., 2000; Roy et al., 2007) .
Cell culture, transfection, and pharmacologic experiments. Hippocampal cultures were obtained from brains of embryonic day 18 (E18)-E19 C57BL/6 mice following standard protocols. Briefly, dissociated cells were plated at a density of 50,000 cells/cm in poly-D-lysine-coated glassbottom culture dishes (Mattek, Ashland, MA) and maintained in Neurobasal/B27 plating media (Invitrogen) supplemented with 0.5 mM glutamine. Cells were transfected with the respective construct(s) using Lipofectamine-2000 (Invitrogen) at 7-8 d in vitro (DIV) according to the manufacturer's instructions, and transport studies were performed at 10 -12 DIV. All animal studies were performed in accordance with University of Pennsylvania guidelines. For the drug experiments, appropriate doses of latrunculin, vinblastine, or nocodazole were added to the plating as well as the imaging media. For some experiments, latrunculin-treated neurons were imaged to visualize transport, immediately fixed/extracted thereafter with the cytoskeleton-stabilizing buffer, and then immediately stained with fluorescent phalloidin. This allowed us to visualize the actin cytoskeleton specifically in the axons wherein we observed transport. For some experiments, dissociated sympathetic neurons were isolated from newborn rat pups as described previously (Francis et al., 2005) . Details of transfection and imaging in these neurons have also been published previously (Roy et al., 2000; Francis et al., 2005) . Microscopy, live-cell imaging, and image analysis. Live-cell imaging, microscopy, and image analysis were performed as previously described (Roy et al., 2007) , except that Hibernate E (low fluorescence; Brainbits, Springfield, IL) supplemented with 2% B27, 2 mM Glutamax, 0.4% D-glucose, and 37.5 mM NaCl was used for imaging (Trivedi et al., 2007) instead of the L-15-based media described previously. We improved our detection of transported particles significantly by focusing on thin axons with low background fluorescence of exogenously expressed proteins. All transport analysis was performed using kymographs as described, using the "multi-line" tool in MetaMorph (Molecular Devices, Sunnyvale, CA) software (Roy et al., 2007) . Images and movies were scaled to maximize bit depth without any additional manipulation. Our dual-cam system for simultaneously visualizing red/green fluorophores was described previously (Roy et al., 2007) . All statistical analyses were performed using Prism software (Graphpad, San Diego, CA). To allow comparison of frequencies between different experimental groups, we standardized our imaging methods by focusing on axons that traverse the length of the chip, thus capturing movies from approximately the same length of axon (Ϸ50 -60 m) in each experiment.
Results

Transport of ␣-synuclein in SCb is interrupted by pauses of variable duration
Since our initial report on live-cell imaging of ␣-synuclein transport (Roy et al., 2007) , we have refined our methods, allowing us to obtain time-lapse movies with greater clarity, mainly by enhancing the signal-to-noise ratio of the moving cargoes. We achieved this by focusing on thin axons that had a very low diffuse fluorescence of the transfected proteins. In such axons, the vectorial movement of the punctate SCb cargoes is usually clear and easily quantified. We also found that the use of mRFP-tagged proteins gives a better signal-to-noise ratio than enhanced GFP-tagged proteins, probably because of their low autofluorescence. One concern with the use of mRFP-tagged proteins is the possibility of aggregation of the fluorescent protein despite its monomeric state, especially when tagged to membraneassociated proteins. In our system, however, we find that exogenously expressed mRFP::␣-SYN is highly enriched at presynapses in mature cultures and also colocalizes precisely with the endogenous axonal mouse ␣-synuclein as shown in supplemental Figure 1 , A and B (available at www.jneurosci.org as supplemental material), indicating that the tagged ␣-synuclein is behaving like its endogenous counterpart. Furthermore, we obtained similar results with a GFP::␣-SYN vector, and in axons expressing both mRFP::␣-SYN and GFP::␣-SYN, the tagged proteins precisely colocalize with each other and move together in the axons, both anterogradely and retrogradely. An example of one such kymograph is shown in supplemental Figure 1C (available at www.jneurosci.org as supplemental material). . Quantitative parameters of ␣-synuclein transport in F-actin-depleted axons. A, Cultured hippocampal neurons were treated with 5 M latrunculin for 18 -24 h to deplete actin filaments, and ␣-synuclein transport was quantified in these axons. Frequency histograms of average anterograde velocities of moving mRFP::␣-SYN particles (excluding pauses) in control (white bars) and latrunculin-treated (black bars) axons are shown. Note that in both groups, ␣-synuclein moves rapidly at a broad range of velocities, and the two groups are statistically similar ( p ϭ 0.8, Mann-Whitney test, two tailed). B, Particles in both control and latrunculin-treated groups move with a range of transport frequencies, and the two groups are statistically similar ( p ϭ 0.4, Mann-Whitney test, two tailed). Wang and Brown, 2002) . We also noted that the pauses were quite variable in duration. Although many particles either did not pause or paused only briefly (Ͻ30 s), other particles paused for longer times, often for several minutes (Fig. 1 A, multiple red  asterisks) . We also saw particles that were immobile for most of the duration of the sequence but later showed bursts of vectorial movement indistinguishable from other moving particles ( Fig.  1 A, bottom) . Particles showing both transient and prolonged pauses were also observed ( Fig. 1 A, double arrowheads) . We also commonly noted objects that did not move throughout the duration of the sequences (typically 5-8 min). Given the natural variation in the duration of the pauses together with the fact that mRFP::␣-SYN objects commonly pause for several minutes between movement events, it seems reasonable that some and perhaps all of the observed objects that did not move are simply paused in their translocation within the axon. In our previous work, we also showed that the frequency of moving SCb cargoes was relatively low (1 object every Ϸ2 min) and notably much lower than the frequency of moving FC cargoes. We now report similar findings with APP, a classic marker of the FC (Koo et al., 1990) . Figure 1 B shows representative kymographs from ␣-synuclein and APP transport. Note the marked difference in the frequencies between the two.
SCb transport is dependent, not on actin filaments, but on microtubules
To test whether actin filaments are required for SCb transport, we evaluated mRFP::␣-SYN transport in neurons depleted of actin filaments by treatment with latrunculin. To maximally deplete actin filaments, neurons were treated with 5 M latrunculin for 18 -24 h. Previous work has shown that these conditions are sufficient to depolymerize Ն90% of F-actin in cultured axons, and we obtained comparable results (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material) (Allison et al., 1998; Francis et al., 2005) . Transport continued unabated in these actin-depleted axons, with velocities and frequencies indistinguishable from those in control neurons (Fig. 2 A, B, Table 1 ). To confirm that our latrunculin treatments effectively depleted actin filaments specifically in the imaged axons, several axons were fixed after imaging and then stained with fluorescein-phalloidin immediately thereafter to reveal remaining actin filaments, if any. In all cases, these retrospective analyses confirmed depletion of actin filaments in the specific axons that showed vectorial movements. A representative example of these data is shown in Figure  3A .
Given that vectorial ␣-synuclein transport does not depend on F-actin, it seems likely that these movements instead require intact microtubules. To test the role of microtubules in SCb transport, we disrupted microtubules in our system using 5 M vinblastine for 3 h and visualized ␣-synuclein transport in these drug-treated axons. We have previously shown that these conditions are sufficient to disrupt microtubules in cultured sympathetic neurons without any detectable change in cell viability (Francis et al., 2005) , and we obtained similar results with our hippocampal cultures (see supplemental Fig. 2 , available at www.jneurosci.org as supplemental material). Microtubule disruption caused approximately sevenfold inhibition of ␣-synuclein transport, with only four vectorial movements seen in 2780 s of imaging (1 movement every 695 s of imaging time). Short-range mergingsplitting of mRFP::␣-SYN-labeled vesiclelike structures continued in these microtubule-disrupted axons, suggesting that other physiologic mechanisms were preserved. A representative example of these data is shown in Figure 4 . These results establish that ␣-synuclein transport in SCb is microtubule dependent. A recent study also showed that ␣-synuclein binds to lipid rafts at presynapses (Fortin et al., 2004 ), so we asked whether ␣-synuclein transport in SCb was mediated via its association with these rafts. To do this, we used 10 g/ml nystatin to acutely disrupt rafts in our cultures as described previously (Fortin et al., 2004) and then visualized mRFP::␣-SYN transport. We observed ␣-synuclein transport before and after adding nystatin, indicating that disruption of lipid rafts does not completely prevent synuclein transport (data not shown).
Finally, we also examined the transport of SCb proteins in a different system to evaluate the generality of the observations with cultured hippocampal neurons by using cultured sympathetic neurons obtained from newborn rats. Because ␣-synuclein is not expressed reliably in these cultures (our unpublished data), we focused on synapsin-I, using a GFP-tagged synapsin-I (GFP:: SYS-I) to label SCb cargoes for live-cell imaging. In every respect examined, GFP::SYS-I transport in these neurons closely resembled that of hippocampal neurons. Specifically, synapsin-I is organized into discrete, punctate structures that are transported rapidly at rates of 1-2 m/s, but transport is infrequent and interrupted by pauses. Disruption of actin filaments with latrunculin had no statistically significant effect on the rate or frequency of synapsin-I transport, thus confirming in a separate system that transport of this SCb protein does not require actin filaments (Table 2) . However, no synapsin-I movements were seen on disrupting microtubules with vinblastine or nocodazole (0 movements in 87 min of imaging time).
Actin filaments do not act as a carrier for multiple SCb proteins
To rigorously assess whether actin filaments function as a carrier or scaffold for SCb proteins, we next determined whether actin filament depletion disrupts the cotransport of SCb proteins. Using our dual-cam system, we have previously shown that ␣-synuclein, synapsin-I, and GAPDH are cotransported as components of an SCb cargo complex (Roy et al., 2007) , and classical transport studies using radioisotopic labeling suggest that many more SCb proteins are cotransported as components of discrete SCb cargoes as well (Garner and Lasek, 1982) . As mentioned previously, it has been suggested that actin filaments are at the core of these cargo complexes, serving as a scaffold to bind directly or indirectly the other SCb proteins. If this is correct, then disruption of actin filaments should disrupt the complex and prevent the cotransport of the component proteins. We tested this by evaluating the cotransport of ␣-synuclein, synapsin-I, and GAPDH in hippocampal neurons depleted of actin filaments by treatment with latrunculin. As shown in Figure 5A , cotransport of red/green-labeled ␣-synuclein/synapsin-I continued despite actin filament depletion. Recently, it was reported that a 10ϫ higher dose of latrunculin (50 M) for much shorter times (2-10 min) can cause an acute disruption of F-actin in cultured hippocampal neurons (Sankaranarayanan et al., 2003) . To provide a more thorough assessment of possible effects of actin filament disruption on SCb transport, we tested this acute treatment regimen as well, and even under these conditions, cotransport of ␣-synuclein, synapsin-I, and GAPDH continues (Fig. 4 B) . Thus, we conclude that actin filaments are not required as a carrier for the cotransport of these SCb proteins.
Discussion
Our purpose in the present studies was to evaluate the role of actin filaments in SCb transport. Actin filaments could participate in SCb transport in two different ways: (1) as a component of the motor system that powers SCb transport and (2) as a scaffold for binding and organizing the transport of SCb proteins. The possibility that actin filaments could have one or both of these functions evolved initially from the identification of actin and myosin in SCb, and this notion was reinforced further by subsequent observations demonstrating that several SCb proteins had actin-binding activity. However, the concept lacked definitive experimental support, and for this reason, we addressed this issue here. Briefly, we focused on three SCb proteins, ␣-synuclein, synapsin-I, and GAPDH, because we previously showed that they are components of a protein complex transported in SCb (Roy et al., 2007) . The present results show unequivocally that the transport of these proteins in SCb continues after pharmacologic treatments that deplete actin filaments and that their transport in these actin-depleted axons is indistinguishable from that in control neurons. Notably, these three proteins continue to undergo cotransport in these actin-depleted axons. Thus, although we cannot completely exclude the possibility that SCb transport is different in adult neurons that are more enriched in F-actin, we provide compelling experimental data to support our conclusion that actin filaments are neither essential components of the motor mechanisms that transport these proteins nor essential as a scaffold for their cotransport in our model system. To what extent do the present findings extend to the transport of the other SCb proteins? This question arises because SCb transports Ͼ200 different proteins, whereas our studies have examined only three of these. Although the available evidence does not allow us to rigorously answer this question, several observations suggest that the present findings extend well beyond these three proteins. Although direct evidence for the cotransport of SCb exists only for the three proteins studied here (Fig. 5 ) (see also Roy et al., 2007) , several indirect observations indicate that the proteins of SCb are organized into much larger multicomponent complexes that are transported in axons. First, radioisotopic labeling studies have provided data suggesting that many of the SCb proteins move together as if they comprised discrete structures that are transported in axons (Willard et al., 1974 (Willard et al., , 1979 Black and Lasek, 1980; Tytell et al., 1981; Lasek, 1981, 1982) . This possibility was reinforced by studies in which large subsets of SCb proteins were isolated by subcellular fractionation (Lorenz and Willard, 1978) or nondenaturing immunoprecipitation (Black et al., 1991) . Finally, a review of the literature reveals that many other SCb proteins interact with the three proteins that are cotransported in our system. For example, a recent study investigating ␣-synuclein binding partners identified several known SCb proteins, including dynein, synapsin-I, components of the ubiquitin system, annexin, and heat shock cognate-70 (hsc70) (Woods et al., 2007) . Several other chaperones and metabolic enzymes were also isolated as ␣-synuclein binding partners in this assay, and although these are not among the limited list of known SCb proteins, we note that such proteins typically move in SCb. Furthermore, interactions of synapsin with the SCb proteins spectrin and calmodulin have been reported (Baines and Bennett, 1985; Nicol et al., 1997) , and the SCb protein MAP-1B was shown to bind to GAPDH, spectrin, and clathrin, all SCb proteins (Cueille et al., 2007) . It is also known that hsc70 exists as a complex with clathrin and a variety of other SCb proteins (Black et al., 1991) . Given our data showing that ␣-synuclein, synapsin-I, and GAPDH are cotransported as a complex and the above described interactions between the three proteins that we studied and other known SCb members, we infer that all these proteins are a part of a transported SCb complex that depends on microtubules rather than on the actin network.
Clearly, more work is required to understand the extent and nature of interactions among the proteins in SCb. In particular, the available information does not conclusively reveal the number of discrete complexes transported by SCb or the specific composition of these complexes. It is also unknown whether these complexes are simply carriers for the delivery of sets of SCb proteins to the axon and axon terminal or whether SCb proteins are organized into discrete complexes on the basis of their functional specializations, as reported for FC cargoes (Sytnyk et al., 2004) . Nonetheless, the considerations summarized above indicate that the potential interactions among SCb proteins are extensive and are consistent with the possibility that ␣-synuclein, synapsin-I, and GAPDH are only three of a much larger number of proteins that comprise a discrete SCb cargo. Also, the studies above showing interactions between various SCb members coupled with our . SCb transport is dependent on microtubules. Cultured hippocampal neurons were transfected with mRFP::␣-SYN and then treated with vinblastine for 3 h to disrupt microtubules. Vectorial movements were greatly diminished under these conditions. A representative image from one such time lapse is shown. Note that elongated clusters of mRFP::␣-SYN were seen along isolated axons that probably represent stalled ␣-synuclein cargoes (asterisks). The kymographs (bottom) from the respective axons above demonstrate that particles do not show any appreciable vectorial transport. Note that merging/splitting of vesicle-like ␣-synuclein clusters (single and double arrowheads, respectively) continues in these axons, leading to short-range movements. :SYS-I, respectively, treated with 5 M latrunculin for 18 -24 h, and visualized by simultaneous dual-color video microscopy. Selected frames from a time-lapse sequence show a single mRFP::␣-SYN particle and a GFP::SYS-I particle cotransported anterogradely (arrowhead, yellow in merged). Kymographs generated from the movies in the red/green channel are shown as well. Note that the two fusion proteins colocalize precisely during transport, suggesting that the ␣-synuclein/synapsin-I complex is not disrupted by actin depletion. B, Axons double transfected with mRFP::␣-SYN and GFP-tagged synapsin-I or GAPDH were treated with a high dose (50 M) of latrunculin, known to cause acute disruption of F-actin, and then imaged with dual-color simultaneous video microscopy. Note that cotransport of ␣-synuclein and synapsin-I or ␣-synuclein and GAPDH continues under these conditions as well.
observations that actin is not required for maintaining the SCb complex suggest that innate affinities among SCb members (and not actin) may be sufficient in maintaining the integrity of these complexes. Additional focused studies are needed to address these issues. Whereas actin disruption has no detectable effect on SCb transport in two different systems, disruption of microtubules with either nocodazole or vinblastine brings SCb transport to a halt. These findings focus attention on microtubules and microtubule motors in powering the movement of SCb cargoes. Presumably one or more of the kinesin family of motors mediates anterograde transport of SCb, whereas dynein mediates retrograde transport. The identity of the specific motors involved is not certain, although biochemical evidence exists for the interaction of kinesin-1 (conventional kinesin) with ␣-synuclein (Utton et al., 2005; Woods et al., 2007) , raising the possibility that this motor contributes to anterograde SCb transport. In this regard, detailed analyses of kinesin-1 transport in pulse-chase studies failed to detect any kinesin-1 moving with SCb (Elluru et al., 1995) . If kinesin-1 does contribute to SCb transport, then one possibility is that its association with the SCb cargoes is transient, thus accounting for the absence of detectable amounts of this motor in SCb. Perhaps the transient association of kinesin-1 with SCb cargoes contributes to the observation that these cargoes pause often for relatively prolonged times during their transit in the axon. Kinesin-1 may dissociate from the cargo so that the cargo remains paused until engaged again by another motor. In this regard, regulation of vesicle transport by kinesin-1 involves site-specific phosphorylation events that control the attachment and detachment of kinesin to its cargoes, and thereby whether the cargo moves or stops (Lee and Hollenbeck, 1995; Morfini et al., 2002 Morfini et al., , 2004 Horiuchi et al., 2005) . Key issues for the future include identifying the specific motors that power SCb transport and determining how they are regulated to produce the stopand-go movement typical of SCb cargoes.
